Want to see MDLN full AI Analyst Report?
Medline (MDLN) Ratios
Medline Ratios
MDLN's free cash flow for Q2 2026 was $604.00M. For the 2026 fiscal year, MDLN's free cash flow was decreased by $-111.00M and operating cash flow was $715.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 4.29 | 3.39 | 4.13 |
| Quick Ratio | 2.37 | 1.56 | 2.34 |
| Cash Ratio | 0.78 | 0.10 | 0.74 |
| Solvency Ratio | 0.11 | 0.11 | 0.06 |
| Operating Cash Flow Ratio | 0.70 | 0.72 | 0.79 |
| Short-Term Operating Cash Flow Coverage | 22.65 | 11.49 | 13.81 |
| Net Current Asset Value | $ -8.52B | $ -11.18B | $ -10.34B |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.33 | 0.47 | 0.47 |
| Debt-to-Equity Ratio | 1.17 | 1.02 | 0.99 |
| Debt-to-Capital Ratio | 0.54 | 0.51 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.54 | 0.50 | 0.49 |
| Financial Leverage Ratio | 3.58 | 2.18 | 2.13 |
| Debt Service Coverage Ratio | 2.44 | 2.38 | 1.71 |
| Interest Coverage Ratio | 2.72 | 1.70 | 1.05 |
| Debt to Market Cap | 0.37 | 0.51 | 0.51 |
| Interest Debt Per Share | 16.47 | 23.13 | 23.13 |
| Net Debt to EBITDA | 4.70 | 4.71 | 5.89 |
| Profitability Margins | |||
| Gross Profit Margin | 26.44% | 24.66% | 22.48% |
| EBIT Margin | 4.39% | 10.02% | 7.06% |
| EBITDA Margin | 7.95% | 13.85% | 11.15% |
| Operating Profit Margin | 7.78% | 8.72% | 6.22% |
| Pretax Profit Margin | 4.39% | 4.88% | 1.14% |
| Net Profit Margin | 4.08% | 4.70% | 1.01% |
| Continuous Operations Profit Margin | 4.07% | 4.70% | 1.01% |
| Net Income Per EBT | 92.87% | 96.31% | 88.64% |
| EBT Per EBIT | 56.42% | 56.00% | 18.28% |
| Return on Assets (ROA) | 3.01% | 3.34% | 0.65% |
| Return on Equity (ROE) | 10.79% | 7.26% | 1.38% |
| Return on Capital Employed (ROCE) | 6.15% | 6.63% | 4.25% |
| Return on Invested Capital (ROIC) | 5.69% | 6.36% | 3.75% |
| Return on Tangible Assets | 7.02% | 8.99% | 1.70% |
| Earnings Yield | 3.40% | 3.72% | 0.73% |
| Efficiency Ratios | |||
| Receivables Turnover | 8.05 | 7.92 | 7.85 |
| Payables Turnover | 21.76 | 22.11 | 25.87 |
| Inventory Turnover | 4.39 | 4.31 | 4.72 |
| Fixed Asset Turnover | 5.95 | 5.12 | 4.84 |
| Asset Turnover | 0.74 | 0.71 | 0.64 |
| Working Capital Turnover Ratio | 4.06 | 4.08 | 0.00 |
| Cash Conversion Cycle | 111.81 | 114.20 | 109.68 |
| Days of Sales Outstanding | 45.36 | 46.06 | 46.51 |
| Days of Inventory Outstanding | 83.23 | 84.64 | 77.28 |
| Days of Payables Outstanding | 16.77 | 16.51 | 14.11 |
| Operating Cycle | 128.59 | 130.70 | 123.79 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 2.15 | 2.25 | 2.14 |
| Free Cash Flow Per Share | 1.60 | 1.78 | 1.78 |
| Dividend Paid and CapEx Coverage Ratio | 1.81 | 4.86 | 5.91 |
| Capital Expenditure Coverage Ratio | 3.90 | 4.86 | 5.91 |
| Operating Cash Flow Coverage Ratio | 0.14 | 0.10 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.07 | 0.07 |
| Free Cash Flow Yield | 3.80% | 4.35% | 4.34% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | 29.37 | 26.97 | 137.91 |
| Price-to-Sales (P/S) Ratio | 1.20 | 1.27 | 1.39 |
| Price-to-Book (P/B) Ratio | 3.18 | 1.95 | 1.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 26.29 | 22.97 | 23.05 |
| Price-to-Operating Cash Flow Ratio | 19.56 | 18.24 | 19.15 |
| Price-to-Earnings Growth (PEG) Ratio | -4.96 | 0.07 | -0.13 |
| Enterprise Value Multiple | 19.80 | 13.85 | 18.35 |
| Enterprise Value | 44.73B | 48.92B | 47.51B |
| EV to EBITDA | 19.80 | 13.85 | 18.35 |
| EV to Sales | 1.57 | 1.92 | 2.05 |
| EV to Free Cash Flow | 34.48 | 34.82 | 33.94 |
| EV to Operating Cash Flow | 25.65 | 27.65 | 28.20 |
| Tangible Book Value Per Share | -3.31 | -7.75 | -6.79 |
| Shareholders’ Equity Per Share | 13.22 | 20.99 | 21.57 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.07 | 0.04 | 0.11 |
| Revenue Per Share | 35.01 | 32.41 | 29.51 |
| Net Income Per Share | 1.43 | 1.52 | 0.30 |
| Tax Burden | 0.93 | 0.96 | 0.89 |
| Interest Burden | 1.00 | 0.49 | 0.16 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.16 | 0.16 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.50 | 1.47 | 7.20 |
Currency in USD
